Prevalence of viral (HBV, HCV and HIV) co-infections among apparently healthy blood donors in Ranchi, Jharkhand, India

Sushma Kumari, Asha Kiran, Ritesh Kumar, Ramesh K. Shrivastava


Background: Apparently healthy blood donors may carry double viral co-infections that might be more fatal than viral mono-infection for the donor himself as well as recipient later on.

Methods: All blood samples were screened for HIV-I and II (4th generation kit), HBV and HCV (3rd generation kit) by using chemiluminescence technique (Manufacturer- Abbott, Model-Architect i 1000SR).

Results: On screening of 41307 blood units, 829 (2.0%) donors were found positive for one of the viral infection (HBV, HCV and HIV). Highest prevalence was for HBV (417 donors- 1.0%) followed by HCV (324 donors- 0.78 %) and HIV (88 donors- 0.21 %).

Conclusions: Apparently healthy blood donors might carry, life threatening, double viral co-infections in their blood. Failure to diagnose and treat co-infection at an early stage results in serious complications and sequelae. For safe blood transfusion all blood units should be tested for compatibility and TTI’s with reduction in unnecessary blood transfusion.


Hepatitis B virus and hepatitis C virus, Human immunodeficiency virus, Transfusion transmitted viral co-infections

Full Text:



Widman FK. American Association of Blood Banks, Arlington- Technical Manual.1985:325-344.

Srikrishna A, Sitalakshmi S, Damodar P. How safe are our safe donors. Indian J Pathol Microbiol. 1999;42:411-6.

Government of India. Drugs and Cosmetics rules, 1945 (amended till 30th June2005). Available from:

National Blood Policy. Produced and published by NACO (National AIDS Control Organization), Ministry of Health and Family Welfare, Government of India, New Delhi. June 2003 (reprint 2007).

Manual on quality standards for HIV testing laboratories. Produced and Published by NACO (National AIDS Control Organization), Ministry of Health and Family Welfare, Government of India, New Delhi. Published in March 2007.

Khan ZT, Asim S, Tariz Z, Ehsan IA, Malik RA, Ashfaq B, et al. Prevalence of transfusion transmitted infections in healthy blood donors in Rawalpindi District, Pakistan–a five year study. Int J Pathol. 2007;5:21-5.

Supram HS, Gokhale S, Sathian B, Bhatta DR. Hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infection among hiv infected individuals at tertiary care hospital in Western Nepal. Nepal J Epidemiol. 2015;5(2):488-93.

Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Res Notes. 2013;6(1):363.

Ben HS, Bahri O, Maamouri N, Cheikh I, Alaya NB, Sadraoui A, et al. Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia. North Africa. Virol J. 2010;15:7-229.

Warda B, Abderrahim F, Noureddine D, Thierry PT, Khadija El, Nadia N, et al. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health. 2013;13:50.

Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis. 1998;17(1):6-13.

Zhang F, Zhu H, Wu Y, Dou Z, Zhang Y, Kleinman N, et al. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study. Lancet Infect Dis. 2014;14(11):1065-72.

Andrew MM, Thembeni LM, Mojakgomo HM, Selokela GS, Tshweu S, Jeffrey MM. Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy. J Med Virol 2015;87(2):213-21.

Rosenthal E, Roussillon C, Salmon C, Georget A, Henard A, Huleux T, et al. Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche surle SIDA (ANRS) EN 20 Mortalité 2010 survey. HIV Med. 2015;6(4):230-9.

Gia LT, Jennifer RK, Zhigang D, Jessica AD, Peter AR, Hashem BE. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2013;58(2):538-45.

Ghimire P, Thapa D, Rajkarnikar M, Tiwari BR. HIV and Hepatitis B co-infection among volunteer blood donors. J Nepal Health Res Counc. 2008;4:26-8.

Athena PK, Marc B, Dale JH, Denise JJ. HIV-HBV Coinfection- A Global Challenge. N Engl J Med 2012;366:1749-52.

Thio CL. Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. Semin Liver Dis. 2003;23(2):125-36.

Sanjiv A, Shalini M, Ankit C, Charoo H. Seroprevalence of Hepatitis B and C Co-Infection in HIV Positive Patients from a Tertiary Care Hospital. JIMSA 2013;26:91-2.

Kranthi K, Shashiraja P, Indira B. Co-infection with hepatitis viruses among HIV-infected individuals at a tertiary care centre in South India. Trop Doct 2011;41:170-1.

Rogers MC, Kumarasamy N, Chaguturu SK. Hepatitis B, hepatitis and HIV co-infection in Chennai, India. Program and Abstract of the 11th Conference on Retroviruses and Opportunistic Infections February 8-11. 2004, San Francisco, California. 2004;11:796.

Mahajan A, Tandon VR, Verma S, Singh JB, Sharma M. Prevalence of tuberculosis, hepatitis B, hepatitis C and syphilis co- infection among HIV/AIDS patients. Indian J Med Microbiol 2008;26:196-207.

Surendra K, Prakash G, Bishnu RT, Ashish CS, Avhishekh G, Manita R. Sero prevalence of HIV and hepatitis C co- infection among blood donors in

Kathmandu valley, Nepal. Southeast Asian J Trop Med Public Health. 2009;40(1):66-70.

Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, et al. Viral interaction and responses in chronic hepatitis C and B co-infected patients with

interferon-alpha plus ribavirin combination therapy. Antivir Ther. 2005;10:125-33.

Hurt CB, Napravnik S, Moore RD, Eron Jr JJ. Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or C. Antiviral Therap. 2014;19(4):415.